- Home
- MNKD vs AMPH Comparison
MNKD vs AMPH Comparison
Compare MNKD & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- AMPH
- Stock Information
- Founded
- MNKD 1991
- AMPH 1996
- Country
- MNKD United States
- AMPH United States
- Employees
- MNKD N/A
- AMPH N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- MNKD Health Care
- AMPH Health Care
- Exchange
- MNKD Nasdaq
- AMPH Nasdaq
- Market Cap
- MNKD 1.9B
- AMPH 1.7B
- IPO Year
- MNKD 2004
- AMPH 2014
- Fundamental
- Price
- MNKD $6.01
- AMPH $35.70
- Analyst Decision
- MNKD Buy
- AMPH Buy
- Analyst Count
- MNKD 6
- AMPH 4
- Target Price
- MNKD $8.92
- AMPH $60.33
- AVG Volume (30 Days)
- MNKD 2.7M
- AMPH 713.7K
- Earning Date
- MNKD 02-25-2025
- AMPH 02-26-2025
- Dividend Yield
- MNKD N/A
- AMPH N/A
- EPS Growth
- MNKD N/A
- AMPH 17.38
- EPS
- MNKD 0.08
- AMPH 3.01
- Revenue
- MNKD $267,200,000.00
- AMPH $723,549,000.00
- Revenue This Year
- MNKD $45.45
- AMPH $16.76
- Revenue Next Year
- MNKD $16.45
- AMPH $8.00
- P/E Ratio
- MNKD $75.81
- AMPH $11.86
- Revenue Growth
- MNKD 51.35
- AMPH 20.33
- 52 Week Low
- MNKD $3.17
- AMPH $34.60
- 52 Week High
- MNKD $7.63
- AMPH $56.88
- Technical
- Relative Strength Index (RSI)
- MNKD 37.75
- AMPH 34.11
- Support Level
- MNKD $5.98
- AMPH $34.60
- Resistance Level
- MNKD $6.32
- AMPH $39.01
- Average True Range (ATR)
- MNKD 0.21
- AMPH 1.53
- MACD
- MNKD -0.04
- AMPH 0.20
- Stochastic Oscillator
- MNKD 20.55
- AMPH 24.94
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.